Kim Zoski

546 citations

12 papers · 480 indexed · h-index 10

Co-authors: Thomas A. Pugsley Lawrence D. Wise David J. Wustrow Thomas G. Heffner Steven Z. Whetzel Hyacinth C. Akunne Thomas R. Belliotti Ann E. Corbin
Topics: Pharmacological Receptor Mechanisms and Effects (6 papers)Receptor Mechanisms and Signaling (5 papers)Neurotransmitter Receptor Influence on Behavior (4 papers)
Cited by: Organic Chemistry Biological Psychiatry Behavioral Neuroscience
Journals: Journal of Medicinal Chemistry Neuropharmacology Progress in Neuro-Psychopharmacology and Biological Psychiatry
Partner nations: United States France

In The Last Decade

Kim Zoski

12 papers receiving 462 citations

Peers

Countries citing papers authored by Kim Zoski

Since Specialization

Citations

This map shows the geographic impact of Kim Zoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Zoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Zoski more than expected).

Fields of papers citing papers by Kim Zoski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Zoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Zoski. The network helps show where Kim Zoski may publish in the future.

Co-authorship network of co-authors of Kim Zoski

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Zoski. A scholar is included among the top collaborators of Kim Zoski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Zoski. Kim Zoski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Martin Pettersson,Brian Campbell,Amy B. Dounay,David Gray,Longfei Xie,Christopher J. O’Donnell,Nancy C. Stratman,Kim Zoski,(unknown),(unknown),(unknown),(unknown)	11
2	Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Amy B. Dounay,Nancy S. Barta,Brian Campbell,(unknown),(unknown),(unknown),(unknown),David Gray,(unknown),(unknown),Samarendra N. Maiti,Daniel F. Ortwine,(unknown),Nancy C. Stratman,Rajendra Subedi,(unknown),(unknown),Kim Zoski	9
3	3-Arylimino-2-indolones Are Potent and Selective Galanin GAL₃ Receptor Antagonists 2006 ·Journal of Medicinal Chemistry ·Michael J. Konkel,Bharat Lagu,Lakmal W. Boteju,(unknown),Stewart A. Noble,Mary W. Walker,Gamini Chandrasena,Thomas P. Blackburn,Sham S. Nikam,Jon L. Wright,(unknown),Tracy F. Gregory,Thomas A. Pugsley,Hyacinth C. Akunne,Kim Zoski,Lawrence D. Wise	43
4	The discovery of PD 89211 and related compounds: Selective dopamine D4 receptor antagonists 2002 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Thomas A. Pugsley,(unknown),Steven Z. Whetzel,Kim Zoski,(unknown),Hyacinth C. Akunne,Robert G. MacKenzie,Thomas G. Heffner,David J. Wustrow,Lawrence D. Wise	12
5	Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant 2001 ·Neuropharmacology ·Hyacinth C. Akunne,Kim Zoski,Steven Z. Whetzel,(unknown),(unknown),François J. Roman,Thomas A. Pugsley	30
6	PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects 2000 ·Neuropharmacology ·Hyacinth C. Akunne,Kim Zoski,M. Duff Davis,(unknown),Leonard T. Meltzer,Steven Z. Whetzel,(unknown),David J. Wustrow,Lawrence D. Wise,Robert G. MacKenzie,Lynn M. Georgic,Thomas G. Heffner,Thomas A. Pugsley	5
7	A Series of 6- and 7-Piperazinyl- and -Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity: Discovery of a Potential Atypical Antipsychotic Agent 1999 ·Journal of Medicinal Chemistry ·Thomas R. Belliotti,David J. Wustrow,(unknown),Kim Zoski,(unknown),Steven Z. Whetzel,Lynn M. Georgic,Ann E. Corbin,Hyacinth C. Akunne,Thomas G. Heffner,Thomas A. Pugsley,Lawrence D. Wise	19
8	Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists 1998 ·Bioorganic & Medicinal Chemistry Letters ·David J. Wustrow,Thomas Capiris,(unknown),(unknown),Hyacinth C. Akunne,M. Duff Davis,Robert G. MacKenzie,Thomas A. Pugsley,Kim Zoski,Thomas G. Heffner,Lawrence D. Wise	111
9	Isoindolinone enantiomers having affinity for the dopamine D4 receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,(unknown),Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Kim Zoski,Steven Z. Whetzel,Ann E. Corbin,Thomas A. Pugsley,Thomas G. Heffner,Lawrence D. Wise	194
10	Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors 1998 ·Journal of Medicinal Chemistry ·David J. Wustrow,Thomas R. Belliotti,Shelly A. Glase,Suzanne R. Kesten,(unknown),Norman L. Colbry,(unknown),A. C. Blackburn,Hyacinth C. Akunne,Ann E. Corbin,M. Duff Davis,Lynn M. Georgic,Steven Z. Whetzel,Kim Zoski,Thomas G. Heffner,Thomas A. Pugsley,Lawrence D. Wise	25
11	Novel cyclohexyl amides as potent and selective D3 dopamine receptor ligands 1997 ·Bioorganic & Medicinal Chemistry Letters ·Thomas R. Belliotti,Suzanne R. Kesten,John R. Rubin,David J. Wustrow,Lynn M. Georgic,Kim Zoski,Hyacinth C. Akunne,Lawrence D. Wise	15
12	Functional activity of new C-terminal cyclic-neurotensin fragment analogs 1996 ·Neuropeptides ·Hyacinth C. Akunne,(unknown),Kim Zoski,Andrea M. Sefler,(unknown),Tomi K. Sawyer,Thomas A. Pugsley,Wayne L. Cody	6

About Kim Zoski

Kim Zoski is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Behavioral Neuroscience, having authored 12 papers that have together received 480 indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). The work is most often cited by research in Organic Chemistry (321 citations), Biological Psychiatry (23 citations) and Behavioral Neuroscience (28 citations). Kim Zoski has collaborated with scholars based in United States and France. Frequent co-authors include Thomas A. Pugsley, Lawrence D. Wise, David J. Wustrow, Thomas G. Heffner, Steven Z. Whetzel, Hyacinth C. Akunne, Thomas R. Belliotti, Ann E. Corbin, Suzanne R. Kesten and John R. Rubin. Their work appears in journals such as Journal of Medicinal Chemistry, Neuropharmacology and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact